Pancreatic Cancer
3 competing products in clinical development for Pancreatic Cancer.
Pipeline by Phase
Phase 11
Phase 22
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| pemetrexed | Eli Lilly | Phase 2 | Completed | 52 |
| mFOLFIRINOX + Ramucirumab | Eli Lilly | Phase 2 | Completed | 52 |
| Cyclophosphamide + GVAX Pancreas Vaccine (GVAX) + Pembrolizumab + IMC-CS4 | Eli Lilly | Phase 1 | Completed | 33 |